damn - just announced a secondary.... | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website
  • Reminder to Premium Members: To enjoy full site functionality & avoid the bugs currently affecting recommend, delete & other features on our "www" pages, please log in to your premium accounts at https://premium.investorvillage.com If you need assistance, don't hesitate to contact customer support any time. That's a big part of what you pay for, after all!  


CALA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2668 of 2686  at  6/19/2019 12:00:35 PM  by

wilderguide


 In response to msg 2666 by  wilderguide
view thread

Re: damn - just announced a secondary....

Let's play "what if..."
What if Susan has applied for BT status for CB-839. They are already on Fast Track, and as a first-in-class glutaminase inhibitor, CANTATA results could be game-changing. ESMO could hold all the cards to answers here, and an early NDA filing aligned with an expedited PDUFA would pump this bad boy back to double digits overnight. Remember, there are still a lot of CALA shareholders that bought in over $10/share. Perhaps this low ball offering is Susan's way of keeping them in the game.


     e-mail to a friend      printer-friendly     remove from library      
| More
Recs: 1     Views: 179
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...